Michigan to limit Medicaid coverage for weight loss drugs to people with diabetes, morbid obesity Michigan's new bipartisan state budget will limit Medicaid coverage of a group of weight loss drugs whose use has exploded in popularity in recent years
The pill is the right choice for some patients and not for others
Managing a body-focused repetitive behavior is best done with a qualified mental-health provider
When stratified by comparator groups, the pooled estimate was most favorable in monotherapy trials versus placebo (SMD 2.41, 95% CI 4.43 to 0.39), whereas the add-on designs versus the same background treatment (SMD 0.65, 95% CI 1.85 to 0.55), head-to-head comparisons versus another drug (SMD 0.19, 95% CI 0.84 to 0.45), and add-on designs versus placebo (SMD 0.65, 95% CI 1.35 to 0.06) showed more modest estimates and did not provide clear evidence of a between-group difference overall (p=0.21)
$175 monthly
Recalls & Warnings November 02, 2012 Maker of Joint Health, Blood Sugar, Prostate, Ginkgo Supplements and More Warned For Drug Claims, Misbranding and Adulteration On September 10, 2012, the FDA issued a warning letter to Global Source Management & Consulting for making drug claims about the following dietary supplements: Scientific Joint Program capsules, Alpha Lipoic Acid, Healthy Blood Sugar Diabetic Support, Dr